Article
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 4 Mar 2018
Siika Abraham, McCabe Leanne, Bwakura-Dangarembizi Mutsa, Kityo Cissy, Mallewa Jane, Berkley Jay, Maitland Kath, Griffiths Anna, Baleeta Keith, Mudzingwa Shepherd, Abach James, Nathoo Kusum, Thomason Margaret J, Prendergast Andrew J, Walker Ann Sarah, Gibb Diana M
Abstract excerpt
Background: Severely immunocompromised human immunodeficiency virus (HIV)-infected individuals have high mortality shortly after starting antiretroviral therapy (ART). We investigated predictors of early mortality and "late presenter" phenotypes. Methods: The Reduction of EArly MortaLITY (REALITY) trial enrolled ART-naive adults and children ≥5 years of age with CD4 counts <100 cells/µL initiating ART in Uganda,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.